Inhibitory effect of vasostatin on migration of pancreatic cancer endothelial cells.
10.3760/cma.j.issn.1674-1935.2012.01.006
- VernacularTitle:Vasostatin基因对胰腺癌内皮细胞迁移的影响
- Author:
Lei LI
;
Jun LIU
;
Xinjian WAN
;
Lungen LU
;
Ping ZHENG
;
Yuwei DONG
;
Chunlan HUANG
;
Xingpeng WANG
;
Yaozong YUAN
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Cell movement;
Endothelial cells;
Anpogenesis inhibitors
- From:
Chinese Journal of Pancreatology
2012;12(1):16-18
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the effect of vasostatin on the migration of pancreatic cancer endothelial cells.Methods Ad-vasostatin with different concentrations of vasostatin was used to transfect pancreatic cancer endothelial cells.Ad-LacZ transfection and PBS was used as control.The effect of vasostatin gene mediated by adenovirus on the migration of pancreatic cancer endothelial cells was measured by woundhealing assay,transwell migration assay,and tube formation assay.ResultsThe scratched lines in PBS group and Ad-LacZ group were almost healed 48 hours later,while the lines in Ad-vasostatin group were rarely healed.At the MOI of 1,2,5,the migration rate of Ad-Laz group was ( 84.7 ± 2.6) ％,(80.7 ± 1.7 ) ％ and (81.3±4.0)％,while the corresponding values were (77.7 ±2.1)％,(67.3 ±2.1)％ and (38.8 ±2.1 ) ％ in Ad-vasostatin group.Transwell migration assay indicated that the number of migrated cells in Advasostatin group was inhibited in a dose-dependant manner,at the MOI of 5,the migration became significantly decreased (F=180.88,P ＜0.05).At the MOI of 1,5,10,the number of tubes in Ad-LacZ group was 118±6,120±6 and 82±5,while the corresponding values were 65±4,21±4 and 4 ±1 in Ad-vasostatin group.The number of tubes of pancreatic cancer endothelial cells was inhibited by Ad-vasostatin in a dose-dependant manner,at the MOI of 10, it was difficult to form the tubes (F-300.85,P＜0.05). Conclusions The vasostatin gene mediated by adenovirus has a significant inhibitory effect on the migation of pancreatic cancer endothelial cells in vitro in a dose-dependent manner.
